Effect of cholecystokinin analogue caeru
โ
Cosimo Sperti; Carmelo Militello; Roubik Behboo; Edwin Khajeturian; Sergio Pedra
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 567 KB
The effects of the cholecystokinin (CCK)-analogue, caerulein, and CCKreceptor antagonist lorglumide (CR-1409) on pancreatic carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) were studied. One hundred thirty rats were divided into the following 10 treatment groups: group 1, DMBA (2-3 mg